Gunilla Osswald
Tracked across 4 events · 25 articles · First seen Apr 21, 2026 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Gunilla Osswald, CEO of BioArctic, will present and comment on the first quarter report during the webcast and teleconference.
May 13, 2026 · 7 articles
Business
On August 19, 2026, BioArctic and Bicara Therapeutics announced a research collaboration agreement to develop a novel antibody-based treatment for glioblastoma, an aggressive brain cancer. The collaboration combines BioArctic's BrainTransporter technology with Mesenkia's KITAIbodies platform,…
Impact: As CEO of BioArctic, Gunilla Osswald announced the collaboration, representing BioArctic's strategic move into oncology.
Aug 19, 2026 · 6 articles
Business
BioArctic announced it will publish its second quarter report for April-June 2026 on August 26, 2026, at 8:00 a.m. CEST. The company invited investors, analysts, and media to a webcast and teleconference at 9:30 a.m.…
Impact: CEO Gunilla Osswald will present the Q2 results during the webcast. Her role is standard for an earnings call.
Aug 19, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Gunilla Osswald live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard